Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Conferences 2020

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Who we help

As the trusted partner to the top 50 global pharmaceutical companies and top 10 contract research organizations, our pharmaceutical data, insights, and analytics are used by businesses operating in all areas of the industry.

Our Specialties

For pharmaceutical companies

Bring game-changing drugs to market more efficiently using our insight and analysis. We’ll help you beat the competition and improve healthcare and patient outcomes.

For contract research organizations

We can help position your organization to win more business and enhance your drug development services. You’ll make better-informed, data-driven decisions while bidding on and implementing clinical trials.

For consultancies

Focus on your clients and expand your business opportunities with Pharma Intelligence. We’ll help you build a complete picture of the fast-changing pharmaceutical market with our insight and expertise.

For marketing agencies

You need to understand and communicate complex information simply and persuasively, often across a variety of channels. We can help with branding, multi-channel communication and more.

For the medtech sector

Your trusted source for industry data, analysis, opinion and news. Access the information you need to inform deal making and business cases for product development and quality control and compliance.

Relevant products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Ask-the-Analyst™

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

HBW Insight

Nestlé To Enter Europe's CBD Market With UK Launch

Nestlé Health Science is expanding its CBD offering outside the US with the UK launch of a dietary supplement formulated by cannabis development firm Geocann.

Topic Consumer EU

View article
Medtech Insight

Lack Of Joined Up Data Must Be Addressed By Registries In New UK Device Legislation

The Cumberlege Review of patient safety delivered a damning verdict on the UK’s health system. Its recommendations must be acted on, says a consensus of stakeholders.

Topic Policy & Regulation Medtech

View article
Medtech Insight

Cognoa Seeks De Novo Clearance For AI-Powered Diagnostic App For Autism After Successful Study

FDA clearance of the ASD Diagnostic app could lead to early diagnosis, improving quality of life of children with ASD and their caregivers.

Topic Diagnostics Digital Health FDA

View article
Generics Bulletin

EMA Endorses Dexamethasone For COVID-19

Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.

Topic Coronavirus Policy & Regulation

View article
Scrip

Coronavirus Update: Moderna And Pfizer Respond To Vaccine Trial Transparency Demands

Moderna led by releasing the trial protocol for its COVID-19 vaccine study, followed by Pfizer, as industry faces demands for transparency.

Topic Coronavirus Manufacturing Clinical Trials

View article
Scrip

First COVID-19 Trial Success For Roche's Actemra, But No Sign It Saves Lives

A composite endpoint conceals Actemra’s lack of mortality benefit – while life-saving dexamethasone gets EMA endorsement.

Topic Coronavirus

View article
Generics Bulletin

AAM Ramps Up US Election Lobbying

The AAM has published a timely guide highlighting various voter issues of concern in the run-up to the US elections, including anti-competitive tactics building on monopoly pricing and weak patent laws. The AAM has also called for policies to encourage generic and biosimilar entry in the market while the guide also focuses on policies around the US supply chain.

Topic US Election 2020 Policy & Regulation

View article
Pink Sheet

Six Pharma CEOs To Testify In House as Democrats, Trump Compete For Attention On Drug Pricing

While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.

Topic US Election 2020 Drug Pricing

View article
Pink Sheet

'March In' Plan Unveiled By Democratic Think Tank: A Battle Biopharma Would Welcome?

In sign of how much has changed in four years, industry might be better off if Biden takes CAP’s advice and launches ‘march-in’ actions to address pricing of COVID products.

Topic US Election 2020 Drug Pricing

View article
Pink Sheet

Biden's Drug Pricing Administrative Actions Could Focus On Medicare Demos

Center for American Progress suggests pricing reforms for the 'next Administration' in lieu of legislation.

Topic US Election 2020 Drug Pricing

View article
Biomedtracker, Datamonitor Healthcare

Key Potential Drug Launches in 2021

Valuable insight and expert analyst commentary 2021’s expected drug launches, their indications, commercial potential, regulatory catalysts and more.

View article
Pink Sheet

What Justice Ginsburg's Death Means For Pharma

A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.

Topic US Election 2020 FDA

View article
Scrip

Dr Reddy's To Steer Russian COVID-19 Vaccine Plans In India

Dr Reddy’s combines forces with the Russian Direct Investment Fund for clinical trials and supply of Sputnik V in India, amid what it views as “very important” data points in early studies of the COVID-19 vaccine.

Topic Coronavirus Vaccines

View article
Scrip

Quick Listen: Scrip's Five Must-Know Things

Join us for a quick audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.

Topic Coronavirus Clinical Trials Vaccines

Full podcast
Scrip

Lilly's Olumiant Cuts COVID-19 Hospital Stays By One Day

Olumiant (baricitinib) plus Gilead’s Veklury (remdesivir) provided a statistically significant reduction in time to recovery versus remdesivir alone for hospitalized patients in US NIAID’s ACTT-2 clinical trial.

Topic Coronavirus Clinical Trials Research & Development

View article